References
1. Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma. Nat Rev Dis Primers. 2019 14;5(1):11.
2. Packer RJ, Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch Neurol. 2008 Nov;65(11):1419–24.
3. Lafay–Cousin L, Bouffet E, Hawkins C, Amid A, Huang A, Mabbott DJ. Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma. Curr Oncol. 2009 Dec;16(6):21–8.
4. Palmer SL, Reddick WE, Gajjar A. Understanding the Cognitive Impact on Children Who are Treated for Medulloblastoma. J Pediatr Psychol. 2007 Oct 1;32(9):1040–9.
5. Ning MS, Perkins SM, Dewees T, Shinohara ET. Evidence of high mortality in long term survivors of childhood medulloblastoma. J Neurooncol. 2015 Apr 1;122(2):321–7.
6. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004 Jul;5(7):399–408.
7. Rodriguez-Galindo C, Friedrich P, Morrissey L, Frazier L. Global challenges in pediatric oncology. Curr Opin Pediatr. 2013 Feb;25(1):3–15.
8. Parkes J, Hendricks M, Ssenyonga P, Mugamba J, Molyneux E, Schouten-van Meeteren A, et al. SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatr Blood Cancer. 2015 Apr;62(4):553–64.
9. Gajjar A, Finlay JL. The management of children and adolescents with medulloblastoma in low and middle income countries. Pediatric Blood & Cancer. 2015;62(4):549–50.
10. Ezzat S, Kamal M, El-Khateeb N, El-Beltagy M, Taha H, Refaat A, et al. Pediatric brain tumors in a low/middle income country: does it differ from that in developed world? J Neurooncol. 2016 Jan 1;126(2):371–6.
11. Azad TD, Shrestha RK, Vaca S, Niyaf A, Pradhananga A, Sedain G, et al. Pediatric Central Nervous System Tumors in Nepal: Retrospective Analysis and Literature Review of Low- and Middle-Income Countries. World Neurosurgery. 2015 Dec 1;84(6):1832–7.
12. Dressler EV, Dolecek TA, Liu M, Villano JL. Demographics, Patterns of Care, and Survival in Pediatric Medulloblastoma. J Neurooncol. 2017 May;132(3):497–506.
13. Baskin JL, Lezcano E, Kim BS, Figueredo D, Lassaletta A, Perez-Martinez A, et al. Management of children with brain tumors in Paraguay. Neuro-oncology. 2013 Feb;15(2):235–41.
14. Flores LE, Williams DL, Bell BA, O’Brien M, Ragab AH. Delay in the Diagnosis of Pediatric Brain Tumors. Am J Dis Child. 1986 Jul 1;140(7):684–6.
15. Kukal K, Dobrovoljac M, Boltshauser E, Ammann RA, Grotzer MA. Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr. 2009 Mar 1;168(3):303–10.
16. Shay V, Fattal-Valevski A, Beni-Adani L, Constantini S. Diagnostic delay of pediatric brain tumors in Israel: a retrospective risk factor analysis. Childs Nerv Syst. 2012 Jan 1;28(1):93–100.
17. Brazil | Data [Internet]. [cited 2019 Jul 8]. Available from: https://data.worldbank.org/country/brazil
18. Institucional [Internet]. INCA - Instituto Nacional de Câncer. 2018 [cited 2019 Jul 8]. Available from: https://www.inca.gov.br/institucional
19. Ferman S, Lima FF da S, Lage CRS, da Hora SS, Vianna DT, Thuler LC. Preventing treatment abandonment for children with solid tumors: A single-center experience in Brazil. Pediatr Blood Cancer. 2019 Jul;66(7):e27724.
20. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma. JCO. 2006 Sep 1;24(25):4202–8.
21. Santos MA, Viégas CMP, Servidoni RA, Barros MHM, Pinel MI, Araújo CMM. Timing of radiation in children with medulloblastoma/PNET. Pediatr Blood Cancer. 2007 Apr;48(4):416–22.
22. Bleil CB, Bizzi JWJ, Bedin A, de Oliveira FH, Antunes ÁCM. Survival and prognostic factors in childhood medulloblastoma: A Brazilian single center experience from 1995 to 2016. Surg Neurol Int [Internet]. 2019 Jun 25 [cited 2020 May 6];10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744760/
23. Johnston DL, Keene D, Kostova M, Lafay-Cousin L, Fryer C, Scheinemann K, et al. Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive. J Neurooncol. 2015 Sep;124(2):247–53.
24. Kombogiorgas D, Sgouros S, Walsh AR, Hockley AD, Stevens M, Grundy R, et al. Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003. Childs Nerv Syst. 2007 Apr;23(4):399–405.
25. Urberuaga A, Navajas A, Burgos J, Pijoán JI. A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years. Childs Nerv Syst. 2006 May;22(5):466–74.
26. Igual Estellés L, Berlanga Charriel P, Cañete Nieto A. Meduloblastoma: mejoría de la supervivencia en las últimas décadas. Experiencia de un centro. Anales de Pediatría. 2017 Jan 1;86(1):4–10.
27. Chan M-Y, Teo W-Y, Seow W-T, Tan A-M. Epidemiology, management and treatment outcome of medulloblastoma in singapore. Ann Acad Med Singap. 2007 May;36(5):314–8.
28. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, et al. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival. Pediatr Blood Cancer. 2019 Jul 1;e27910.
29. Wong T-T, Liu Y-L, Ho DM-T, Chang K-P, Liang M-L, Chen H-H, et al. Factors affecting survival of medulloblastoma in children: the changing concept of management. Childs Nerv Syst. 2015 Oct;31(10):1687–98.
30. Chen S-H, Liu L-Y, Jaing T-H, Tseng C-K, Lin K-L, Lui T-N. Multivariate survival analysis of children with medulloblastoma–a single-center experience. Pediatr Hematol Oncol. 2008 Sep;25(7):647–54.
31. Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, et al. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge. J Clin Oncol. 2015 Sep 20;33(27):3065–73.
32. Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, et al. Feasibility and Response to Induction Chemotherapy Intensified With High-Dose Methotrexate for Young Children With Newly Diagnosed High-Risk Disseminated Medulloblastoma. JCO. 2004 Dec 15;22(24):4881–7.
33. von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, et al. Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol. 2011 Jun;13(6):669–79.
34. Quilty R. Mind the Gap: Improving Pediatric Cancer Care in Developing Countries. University of Ottawa Journal of Medicine. 2016 Nov 30;6(2):40–2.